Avobis Bio Gets FDA Fast Track for AVB-114 Crohn’s Therapy
Only implantable cell therapy for Crohn’s perianal fistulas with FDA IND clearance and Fast Track designation Avobis Bio LLC, a clinical stage company developing implantable...
Category : Healthcare and Pharmaceutical
Foresight Diagnostics Expands Partnership with Allogene Abroad
Expanded collaboration agreement with Allogene includes investment for further MRD assay development, clinical sample testing, milestone payments, and international expansion Foresight Diagnostics (“the Company”), a...
EpiVax Enhances Tech Leadership with Immunoinformatics Breakthroughs
EpiVax, Inc. proudly announces the appointment of Guilhem Richard as Chief Technology Officer. Dr. Richard joined EpiVax’s immunoinformatics team in 2014 and spearheaded the development of a...
IPA & RIBOPRO Partner to Advance mRNA Antibody Discovery
ImmunoPrecise Antibodies Ltd. (NASDAQ: IPA) (“IPA” or the “Company”), a global leader in AI-powered antibody discovery and development, today announced a strategic collaboration with RIBOPRO,...
Thermo Fisher Launches CorEvitas SLE Registry & Biorepository
Thermo Fisher Scientific Inc., the world leader in serving science, today announced the launch of the CorEvitas Systemic Lupus Erythematosus (SLE) Registry. The multi-center, prospective...
Nielsen BioSciences Completes Enrollment in Phase 3 CANDIN Trial
325 subjects enrolled across the United States and Japan in the first Phase III clinical trial for the treatment of warts in children and adults....
Argobio and Institut Pasteur Launch Enodia for Protein Degradation
Argobio and the Institut Pasteur proudly announce the launch of Enodia Therapeutics, a groundbreaking French biotech company dedicated to block and degrade disease-causing proteins for...
eClinical Solutions Announces Strong 2024, New Products for Biopharma
Company prioritizes efficiency through innovation with new embedded AI and automation platform capabilities, including a GenAI-Powered Chatbot and Clean Progress Tracking eClinical Solutions LLC, a...
Emalex Biosciences’ Lead Candidate Hits Endpoints in TS Study
Topline data from Phase 3 study in patients with Tourette syndrome shows statistical significance between ecopipam and placebo for both the primary efficacy endpoint in...
Humanetics CMO Featured at U.S. Industry, National Security Forum
Humanetics Corporation, an advanced clinical-stage specialty pharmaceutical company developing radioprotectant drugs for warfighters and patients with cancer and inflammatory lung diseases, today announced that its...
AON Launches Cloud-Based LIS to Streamline Pathology Reporting
SigmaCore’s easy-to-use platform, LabVizor integrates complex pathology reports into a streamlined, comprehensive system to enhance efficiency for AON’s pathology and oncology labs American Oncology Network...
David Ross Appointed Chief Financial Officer of KPC Health
KPC Health is proud to announce the appointment of C. David Ross, MBA, as Chief Financial Officer (CFO). With over 30 years of executive experience...
Fuse Vectors Secures $5.2M to Advance Gene Therapy Tech
Danish biotech replaces 1980s cell-based methods with revolutionary cell-free technology, making gene therapy more accessible. Innovative approach allows for unprecedented quality in hours rather than...
AscellaHealth Expands Leadership to Drive Growth and Innovation
AscellaHealth, a global partner delivering customizable solutions to support the specialty pharmaceutical industry, today announced the appointment of two senior leaders: Clayton Edwards, RPh, MBA,...
Median Technologies to Showcase eyonis™ LCS at ECR for Lung Cancer
Median Technologies (FR0011049824, ALMDT, PEA/SME eligible, “Median” or “The Company”), a leading developer of eyonis™, a suite of artificial intelligence (AI) powered Software as a Medical...